| Quarter | Score |
|---|---|
| 2022-Q1 | 49.4 |
| 2022-Q3 | 40.9 |
| 2022-Q4 | 50.0 |
| 2023-Q1 | 49.3 |
| 2023-Q2 | 64.0 |
| 2023-Q3 | 48.0 |
| 2023-Q4 | 65.6 |
| 2024-Q1 | 70.9 |
| 2024-Q2 | 51.6 |
| 2024-Q3 | 83.9 |
| 2024-Q4 | 74.3 |
| 2025-Q1 | 54.4 |
| 2025-Q2 | 74.3 |
| 2025-Q3 | 74.4 |
| 2025-Q4 | 74.7 |
| 2026-Q1 | 74.5 |
| 2026-Q2 | 74.6 |
Funds reducing exposure or consensus momentum fading
Within 0.0% of funds' estimated purchase price
2 of 18 tracked funds hold ALLY. Avg conviction: 0.2%. Net trimming. First tracked at $39.31 (current -4.1% vs tracked).
Berkshire Hathaway has 0.4% in this stock
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Berkshire Hathaway | 0.4% | Reduce |
| Citadel Advisors | 0.0% | Reduce |